Clinical Trial Update: A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating PET/CT with the investigational agent [18F] Fluciclatide to correlate imaging with anti-cancer therapy response has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fluciclatide (Fluciclatide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers | Phase 1 | Status: WITHDRAWN